Human induced pluripotent stem cells (hiPSCs) are a most appealing source for cell replacement therapy in acute brain lesions. We evaluated the potential of hiPSC therapy in stroke by transplanting hiPSC-derived neural progenitor cells (NPCs) into the postischemic striatum. Grafts received host tyrosine hydroxylase-positive afferents and contained developing interneurons and homotopic GABAergic medium spiny neurons that, with time, sent axons to the host substantia nigra. Grafting reversed stroke-induced somatosensory and motor deficits. Grafting also protected the host substantia nigra from the atrophy that follows disruption of reciprocal striatonigral connections. Graft innervation by tyrosine hydoxylase fibers, substantia nigra protection, and somatosensory functional recovery were early events, temporally dissociated from the slow maturation of GABAergic neurons in the grafts and innervation of substantia nigra. This suggests that grafted hiPSC-NPCs initially exert trophic effects on host brain structures, which precede integration and potential pathway reconstruction. We believe that transplantation of NPCs derived from hiPSCs can provide useful interventions to limit the functional consequences of stroke through both neuroprotective effects and reconstruction of impaired pathways.
human origin (5, 7, 27, 35, 47, 53) . Encouraging experimental data have fostered Phase I-II trials, so far published with BMSCs and neural cell lines (3, 24) .
Induced pluripotent SCs (iPSCs) (45) have added a unique source to the panel of available resources for SC therapy. IPSCs possess the cardinal features of ESCs, pluripotency and unlimited self-renewal, which are definitive assets for the large-scale and standardized production of therapeutic products. In addition, hiPSCs have the potential to overcome immune rejection with human leukocyte antigen (HLA)-specific cells (23, 34) . On the iPSCs "dark side," reprogramming can leave epigenetic and genetic
IntRODuCtIOn
Despite decades of academic and industrial research, cerebrovascular diseases continue to thwart the attempts of developing neuroprotective treatments and remain a leading cause of death and long-term disability worldwide (49) . The proof of principle of stem cell (SC) therapy in stroke has been provided at experimental level with a wide array of cell sources that, not exhaustively, include neural progenitors from fetal and adult neural tissues, mesenchymal SCs from bone marrow (BMSCs) or umbilical cord blood, peripheral blood cells, immortalized cell lines, and embryonic SCs (ESCs) of rodent, primate, and modifications (17, 21, 28, 48) with still unknown functional repercussions. As a result, the fate and effects of iPSC-derived neural progeny must be thoroughly investigated in preclinical models before therapies based on hiPSCs are proposed to clinicians (10).
In contrast with the unprecedented therapeutic options offered by iPSCs, illustrations of therapeutic transplantation applications are still scarce. Thus far, two reports have described iPSC transplantation in stroke models, firstly, confirming their ability to form teratoma after intracerebral transplantation (20) and, secondly, showing a reduction of stroke-induced motor dysfunction after subdural transplantation with fibrin glue (9). Both reports were performed with undifferentiated mouse iPSCs, leaving the potential of human neural derivatives unexplored.
In this study, hiPSC-derived neural progenitor cells (NPCs) were used to define their ability to reverse strokeinduced functional and structural impairments after intracerebral transplantation. Our results show that hiPSC-NPCs not only rescue sensorimotor and motor functions but protect remote areas connected with the lesioned site from atrophy. Mismatches in the kinetics of functional and structural events suggest the existence of sequential mechanisms, independent, then dependent, on homotopic cell replacement and reconstruction of lost pathways.
MateRIalS anD MetHODS

Validation of hiPSC Lines and Neural Induction
The I-Stem-Strasbourg (I-S)hiPSC lines were derived from MRC5 and IMR90 human fetal lung fibroblasts (ATCC, Manassas VA, USA) transduced with the pSin-EF2-octamer-binding transcription factor 4 (Oct4)-Pur, pSin-EF2-sex-determining region Y Box 2 (Sox2)-Pur, pSin-EF2-Nanog-Pur, and pSin-EF2-Lin28-Pur13 plasmids from Addgene (Cambridge, MA, USA) according to Yu et al. (52) . Viruses were produced by Vectalys (Labège, France; MOI between 7 and 23). The culture medium (Dulbecco's modified Eagle medium containing 10% fetal bovine serum) was progressively modified over 1 week to serum-free hESC medium containing 20 ng/ ml basic fibroblast growth factor (bFGF; R&D Systems, Minneapolis, MN, USA). Transduced fibroblasts were seeded onto mouse embryonic feeder cells and grown in hESC medium. Colonies with ESC morphology appeared after 3-6 weeks and were clonally expanded for 5 weeks with mechanical passage every 5-7 days. Seven colonies from IMR90 and five from MRC5 cultures were selected on a morphological basis and validated for the expression of hESC self-renewal genes and surface markers and for pluripotency through embryoid bodies and teratoma formation before commitment into the neural lineage. Data were compared to hESC lines that included the SA001 (XY; Cellartis AB, Gothenburg, Sweden), H9 (XX; WiCell, Madison, WI, USA), and CCTL14 (XX; Masaryk University, Brno, Czech Republic) lines.
Quantitative PCR Analysis
Real-time quantitative (q) PCR (Primer list in Table 1 ) was performed with the RNeasy microkit (Qiagen, France) and Superscript III reverse transcriptase (Invitrogen, France) on 0.5 µg cDNA. Normalization was achieved against glyceraldehyde 3-phosphate dehydrogenase (GAPDH) RNA using the DDCt method for quantification (ABI-Prism Software, Applied Biosystems).
Flow Cytometry Analysis
Flow cytometry (FACSCalibur Flow Cytometer, BD Biosciences) analysis of the ESC-specific cell surface markers stage-specific embryonic antigen-1 (SSEA-1) [mouse IgM coupled to allophycocyanin (APC)], SSEA-4 (mouse IgG3 coupled to Alexa-Fluor 488), and TRA-1-81 [mouse IgM coupled to phycoerythrin (PE)] was performed CTGCAGTGTGGGTTTCGGGCA  168  NANOG  CAAAGGCAAACAACCCACTT  TCTGCTGGAGGCTGAGGTAT  158  SOX2  ACAGCAAATGACAGCTGCAAA  TCGGCATCGCGGTTTTT  67  KLF4  TATGACCCACACTGCCAGAA  TGGGAACTTGACCATGATTG  110  LIN28  GGCAGTGGAGTTCACCTTT  GCTTCTGCATGCTCTTTCCT  123  DNMT  CCAATCCTGGAGGCTATCCG  ACTGGGGTGTCAGAGCCAT  152  CRIPTO  AAGATGGCCCGCTTCTCTTAC  AGATGGACGAGCAAATTCCTG  108  CK18  TGAGACGTACAGTCCAGTCCT  GCTCCATCTGTAGGGCGTAG  114  KDR  AGCGATGGCCTCTTCTGTAA  ACACGACTCCATGTTGGTCA  172  SOX17  CCTGGGTTTTTGTTGTTGCT  GCTGTTTTGGGACACATTCA  206  AFP  ACTGCAATTGAGAAACCCACTGGAGATG  CGATGCTGGAGTGGGCTTTTTGTGT  192  GAPDH  ATGGGGAAGGTGAAGGTCGGAG  TCGCCCCACTTGATTTTGGAGG on the selected clones and on SA001 with appropriate isotype controls (all antibodies from BD Biosciences).
Embryoid Bodies Formation
Embryoid bodies (EBs) were formed after collagenase dissociation (1 mg/ml, Invitrogen) and seeding on ultralow attachment plates (Nunc, Dutscher) for 3-6 weeks without bFGF. EBs were analyzed after 4 and 14 days by qPCR for markers of the three germ layers.
Karyotype Analysis
I-ShiPSCs were harvested for metaphase chromosomes at 70% confluence. G-banding chromosome analysis was performed with the Wright/Giemsa (Merck) technique after colchicine (20 mg/ml, Eurobio) incubation, hyptonic shock (KCl 0.057 M), and fixation with Carnoy's solution (3:1 methanol/acetic acid). Analysis was performed with the Ikaros software (MetaSystems, Altussheim). Multicolor fluorescent in situ hybridization (mFISH) were performed at passages 18 (both lines) and at p56 (I-I90) or p59 (I-M5) with the cocktail painting Probe Cy5 B-tect detection kit and Isis software (MetaSystems, Altussheim).
Teratoma Formation
Pluripotency was further investigated with the teratoma test performed in nonobese diabetic/severe combined immunodeficient mice (NOD/SCID; Charles River, France) after subcutaneous injection of 2 ´ 10 6 cells, with anatomo-pathological analysis 2 months postinjection.
Neural Induction
Early neural precursors (ENPs) were produced in lowattachment cultures in the presence of Noggin (R&D Systems), the transforming growth factor-b pathway inhibitor SB431542 (Tocris Biosci.), bFGF (10 µg/ml, Preprotech), and human brain-derived growth factor (hBDNF; 20 µg/ml, R&D Systems) (8). NPCs were produced from ENPs in the presence of 20 ng/ml hBDNF for 7 days. Expression levels of pluripotency and neural cell markers were quantified by qPCR and flow cytometry, respectively. Fluorescence-activated cell sorting (FACS) antibodies included anti-Nanog, TRA-1-60 and SSEA4 (eBioscience), CD29, CD15 (SSEA1), CD56 (neural cell adhesion molecule, NCAM), and bIII-tubulin (all from BD Pharmingen), along with unconjugated mouse primary antibodies against nestin and neurofilament 70 kDa (NF70) (Abcam), secondary rat anti-mouse IgG conjugated with fluorescein isothiocyanate (FITC; eBioscience), and secondary donkey anti-rabbit IgG conjugated with APC (Jackson ImmunoResearch Labs).
Voltage clamp was used to record potassium outward current in the whole-cell configuration (20-25°C) filtered at 3.3 kHz, using the HEKA data acquisition/analysis system. Pipettes (5-7 MΩ) were pulled from borosilicate glass with P97-sutter and filled with (mM): KCl 155, MgCl 2 2, CaCl 2 1, HEPES 10, and EGTA 10 (pH 7.3). Cells were maintained in (mM): NaCl 150, CaCl 2 3, KCl 2.5, MgCl 2 1, HEPES 10 (pH 7.6). Steps of +10 mV from the holding voltage Vh-90 mV were applied during 50 ms to record A-type calcium current (IA), 500 ms to record delayed rectifying current (IDR), and 50 ms to record voltage-gated sodium current (INa).
Experimental Surgery
All animal experimentation was performed in compliance with European ethical guidelines (86/609/EEC). Adult male (280 g) Sprague-Dawley rats (Charles River; n = 187) were anesthetized (1-2% isoflurane/30% oxygen/75% nitrous oxide) before receiving a 90-min middle cerebral artery occlusion MCAO (30) with a heparinized 4.0 nylon monofilament (Doccol Corporation; (40) SPPK5; MyDesign MCAO suture PK5; coating length 2-3 mm, tip diameter 0.35 ± 0.02 mm). Rectal temperature was maintained between 36.7°C and 37.5°C with a homeothermic blanket (Harvard Apparatus). Three animals died during MCAO surgery, either during anesthesia (n = 1) or at reperfusion (n = 2). One week after MCAO, animals were randomly distributed into four groups: Control (MCAO nongrafted; n = 35), I-I90-NPC (n = 29), I-M5-NPC (n = 29), and SA001-NPC (n = 15). A group of nonlesioned/nongrafted animals (n = 12) was also used for quantification of substantia nigra (SN) volumes. Grafted animals received a stereotaxic injection of 1 µl of culture medium (Control) alone or containing 100,000 NPCs from I-I90, I-M5, or SA001 (coordinates from bregma A-P: 0.5 mm; Lat: 2 mm; D-V: 5.5 mm) with a needle inclination of 15° to reach the lesion cavity in the lateral quadrant of the striatum. Three additional animals died during this procedure (two during anesthesia, one from bleeding at removal of the needle), resulting in a final distribution of Control (n = 34), I-I90-NPC (n = 28), I-M5-NPC (n = 29), SA001-NPC (n = 14). Animals were immunosuppressed with a daily injection of 10 mg kg -1 cyclosporine A (Sandimmun, Novartis) starting the day before transplantation for 2 months. Body weight was followed daily.
Behavioral Analysis
All behavioral tests were conducted by investigators blinded to the experimental conditions. To avoid habituation of animals to repeated behavioral investigation (18), I-I90-NPC-grafted animals were used for the adhesive removal test and I-IM5-NPC-grafted animals for the staircase test. Animals grafted with I-I90-, I-M5and SA001-NPCs were used for the apomorphin-induced rotation test. For the adhesive removal test (I-I90: n = 28; Nongrafted: n = 19 at the start of experiment), a sticky colored paper dot (12 mm diameter) was placed on the rat left palm and fingers, and the time to remove the dot was measured. Rats were pretrained for 4 days before MCAO and were tested three times a week. The staircase test was performed with sucrose pellets (Campden Instruments Ltd.; three pellets on each side). Animals (I-M5: n = 29; Nongrafted: n = 15 at the start of the experiment) were food-deprived to 85% of their normal weight and trained for 3 weeks (two trials per day, 5 days a week) before MCAO and three times a week after transplantation. Scores indicate the number of pellets grasped by the paw contralateral to the lesion. The apomorphin-induced rotation test (motor dysfunction, pharmacological) was performed on grafted (I-I90: n = 28; I-M5: n = 29; SA001: n = 14 at the start of the experiment) and on nongrafted (n = 34) animals. Turns were counted during 30 min following intraperitoneal injection of 1 mg/kg apomorphin-HCl (Sigma). Deficits were quantified using the formula modified from Arvidsson et al (2)
where IpsiCyl: rotation ipsilateral to the lesion around central cylinder, IpsiItself: rotation ipsilateral on itself, ContrCyl: rotation contralateral to the lesion around the central cylinder, ContrItself: rotation contralateral on itself. Neurological severity scores (NSS) were performed on all groups up to 4 months postgrafting (39). Function was graded on a 0 (normal) to 10 (severely impaired) scale.
Tissue Processing
Rats were anesthetized with 150 mg/kg sodium pentobarbital before intracardiac perfusion with 4% paraformaldehyde phosphate-buffered to pH 7.4. Brains were postfixed overnight in the same fixative solution and cryoprotected with 30% sucrose for 48 h. Thirty-micrometerthick cryostat sections were serially collected with a Leica CM cryostat. Immunohistochemistry was performed with rabbit polyclonal antibodies to human nestin (Chemicon, AB5922), glial fibrillary acidic protein (GFAP; Sigma, G9269), dopamine-and cAMP-regulated neuronal phosphoprotein (DARPP-32; Santa Cruz Biotech., sc-21601), paired box protein 6 (Pax6; Covance, PRB-278P), unspecific tyrosine hydroxylase (TH; Jacques Boy, 208020234), Ki67 (Abcam, ab833), and neuron-specific class III betatubulin (TUJ1; Covance, MMS-435P) and with mouse IgG antibodies to human nuclei (HNA; Chemicon, MAB1281), human mitochondria (MTCO2, Abcam, 3298), Oct4 (Santa Cruz Biotech., SC-5279), human NCAM (SantaCruz Biotech., sc-106), and microtubuleassociated protein 2 (MAP2; Sigma, M1406). Secondary antibodies were Alexa488-or Alexa555-labeled (A11001 and A21428, respectively, Invitrogen). IB4 labeling was performed with isolectin Griffonia simplicifolia (GS)-IB4 biotin conjugate (Invitrogen, I2141) and revealed with Alexa647 (Jackson Labs., 016-600-084). DAPI (4¢,6-diamidino-2-phenylindole) was used to visualize the nuclei. Colorimetric immunohistochemistry was performed using a Discovery XT (Ventana) staining automate. Controls were performed with the corresponding isotype when available or with secondary antibodies only. Observations were made using a Zeiss Axioplan microscope, and image analysis was performed with ImageJ (http://rsb.info.nih.gov/ij). Confocal microscopy was done on a Zeiss LSM Pascal Exciter microscope. Ki67-, DARPP-32-and TH-positive neuron counts were performed with unbiased stereological evaluation on three (Ki67) or six (DARPP-32) consecutive 30-µm-thick sections at 120-µm interval. TH-positive neuron counts were performed from level -4.8 to -6.3 from bregma, independently of the SN volume. Volumes were calculated using the FreeD software (1).
Magnetic Resonance Imaging (MRI)
MRI was performed using a 4.7-T Bruker spectrometer equipped with a custom made surface coil. A T2-weighted turbospin echo sequence rapid acquisition with relaxation enhancement [RARE; repetition time (TR) = 3,000 ms, effective echo time (TE) = 36.0 ms, turbo factor = 8, number of acquisitions (AC) = 8, field of view = 3.5 cm, matrix = 256 ´ 256, slice thickness = 0.85 mm, acquisition time = 9¢36²] was used.
Statistical Analysis
Data are expressed as means ± standard deviation. Statistical analyses were performed using the JMP software (SAS). A value of p < 0.05 was considered significant.
Data were analyzed using one-way or repeatedmeasures ANOVA and Student's t test, with Bonferroni-Dunn post hoc test.
ReSultS
Production of hiPSC and Transplants
The two I-ShiPSC lines, I-I90 (XX) (25) and I-M5 (XY), were validated by comparison to the SA001 (Cellartis AB) and H9 (WiCell) hESC lines ( Figs. 1 and 2) . I-ShiPSC presented all characteristics of pluripotent SCs, including morphology ( Fig. 1A, B ), expression of hESC-specific markers (Fig. 1C-E) , methylation pattern on OCT4 and NANOG promoters (Fig. 1F) , and karyotype stability (Fig. 1G, H ). I-ShiPSCs were able to produce EBs ( Fig. 2A, B ) with hESC-like gene expression ( Fig. 2C , D) and formed teratoma after implantation into the immunodeficient mouse ( Fig. 2E-H) . Early neural precursors (ENPs) were derived using the dual-small body size mothers against decapentaplegic (SMAD) inhibition protocol described for hESCs ( Fig. 3 ). Rosette-like ENPs (Fig. 3A) contained Nanog (Fig. 3B ), Pax6 (Fig. 3C ), and no Oct4 (Fig. 3C ). RT-PCR revealed elevated levels of Nanog mRNA in I-ShiPSC-ENPs (Table 2) . I-M5-ENPs additionally exhibited elevated Sox2 mRNA contents (Table 2) . Nanog mRNA levels were no longer elevated in NPCs (Fig. 3H) , which displayed levels of neuronal differentiation markers similar to hESC-NPCs (Fig. 3H ). NPCs were uniformly labeled for Sox2 ( Fig. 3D) and contained TUJ1-positive neurons (Fig. 3D ) and a small proportion of GFAP astrocytes (Fig. 3E) . Neuronal differentiation was confirmed with electrophysiology ( Fig. 3I ) (see legend). The ability of I-ShiPSC-NPCs to maintain their neuronal commitment into a rat brain environment was assessed in vitro by seeding on primary cultures of embryonic rat cortex (Fig. 3F) . Neuronal differentiation was observed within 2 days (Fig. 3G) . Figure 4 depicts the global scheme of the experiments.
hiPSC-NPCs Differentiate Into GABAergic Neurons
After Transplantation Into the Postischemic Brain As previously described in this paradigm (40), 90 min MCAO resulted in a lesion restricted to the lateral quadrant of the striatum (Fig. 5A ) in 65% of the animals. The other animals had larger lesions, encompassing the cortical and subcortical territories of the artery (Fig. 5B) , and were not kept in the study. One month after transplantation, grafts could be identified on T2-weighted MRI (Fig. 5C ) and histology (Fig. 5D ). Cells were packed at injection site, with some scattered into the proximal parenchyma (Fig. 5E ), and were mainly nestin positive (Fig. 5F ). Grafts also contained cells positive for Sox2 ( Fig. 5G) and Pax6 (Fig. 5H ), but not for Oct4 ( Fig. 5G) , indicating sustained neural commitment in the postischemic environment. Host-graft interactions were illustrated by human MAP2 processes entering the host tissue ( Fig. 5I ) and by patches of host-derived tyrosine hydoxylase (TH)-positive axons (Fig. 5J ) into the grafts. DARPP-32-positive neurons with an immature morphology were distributed in patches over the whole graft, indicating FaCInG COluMn that some NPC had initiated terminal differentiation (Fig. 5M) . Similar results were obtained with SA001-NPCs (Fig. 5K, L) After 4 months, the graft had spread into the lesion cavity, although enlargement of the lateral ventricle was still visible (Fig. 6A ). Grafts formed a mixed tissue with host-derived blood vessels ( Fig. 6B ) and astrocytes (Fig. 6C ). GABAergic striatal neurons formed clusters of fully differentiated hDARPP-32-positive neurons ( Fig. 6D, E) and scattered calretinin-positive interneurons ( Fig. 6F) were observed. In addition to DARPP-32, a D1-receptor-linked protein, a subpopulation of grafted neurons had type 2 dopaminergic receptors (Fig. 6G) . The number of DARPP-32 neurons was not significantly different among grafts from the three cell types: SA001: 172.43 ± 7.65 cells/mm 3 ; I-M5: 140.59 ± 10.74 cells/mm 3 ; I-I90: 162 ± 13.04 cells/mm 3 (one-way ANOVA: p = 0.84; F = 0.18; dll = 19). Sustained proliferation is a major side effect after grafting NPC into the lesioned striatum. Quantification of the mitotic activity with Ki67 immunoreactivity identified 2.34 ± 0.3% dividing cells in grafts at 4 months. However, the absence of colocalization with the human mitochondrial marker MTCO2 indicated that these cells were of host origin (Fig. 6H) . No nonneural structures and no overgrowths were observed along the 4 months of the study.
hiPSC-NPCs Rescue Functional Impairments
Scoring of sensorimotor dysfunction (Fig. 7) with the tape removal test indicated a significant recovery of grafted animals from 2 weeks posttransplantation (Fig. 7A ). Significance was maintained over the 4 months of the study, in spite of an important recovery in nongrafted animals. As reported, MCAO animals typically displayed severe long-lasting motor asymmetry in the apomorphin-induced rotation test (Fig. 7C) . Grafting firstly decreased the aggravation observed between 15 and 45 days post-MCAO and, from 2 months, significantly reduced the deterioration. Baseline scores were comparable in the three groups, indicating the absence of an initial unbalance in rotation scores: SA001: 42.5 ± 24.52; ; one-way ANOVA: p = 0.36; F = 1.10; dll = 39. Other tests [Montoya staircase ( Fig. 7B ) and neurological scores] were not informative due to spontaneous resuming of pre-MCAO scores in nongrafted animals.
hiPSC-NPCs Project to Correct Target Areas
We used the hNCAM antibody to identify projections from grafted cells. One month after transplantation, hNCAM fibers were observed in myelinated fiber bundles of the host striatum and in the globus pallidus ( Fig. 8A, B) at a maximal distance of 2 mm caudal to the injection site. No human fibers were observed in the host SN (Fig. 8C) . After 2 months, human axons had extended throughout the entopedoncular nucleus (Fig. 8D, E) to the most caudal part of the SN (Fig. 8F-G) . A dense graftderived axonal network was observed in SN pars reticulata (SNr) (Fig. 8H) , in close association to TH-positive dendrites (Fig. 8I) . A few hNCAM fibers were observed in the thalamus and in the corpus callosum.
hiPS-NPCs Limit Secondary Neurodegeneration in the Host Brain
T2-weighted MRI in MCAO animals revealed a persistent atrophy of the hindbrain at the level of the SN (Fig. 9A) , which was confirmed at one month by TH staining (Fig. 9B) . At 1 month, MCAO animals had a reduced SNr volume on the side ipsilateral to the lesion (61.1 ± 16.8% reduction compared to nonlesioned/nongrafted animals; p = 0.010) (Fig. 9D ). Figure 9C shows ENPs are thawed when MCAO is performed and are committed to NPCs for one week before transplantation. Animals were followed with magnetic resonance imaging (MRI) and behavioral analysis over 4 months, and histological data were acquired at 1, 2, and 4 months. Diff., differentiation; amplif., amplification; Behav., behavioral analysis; Histo., histological analysis; d, days post-MCAO.
that variations among the three groups (SA001-NPCs, I-I90-NPCs, I-M5-NPCs) were not significant [one-way ANOVA: SN pars compacta (SNc): p = 0.66, F = 0.43, dll = 17; SNr p = 0.59, F = 0.54, dll = 17). Grafting reduced the atrophy of pars reticulata to 27.13 ± 11.50% (Fig. 9D ) (p = 0.017, t = 2.26, dll = 8). MCAO-induced reduction of the volume occupied by TH cell bodies in pars compacta was not significant. However, nonbiased stereological quantification of TH-positive cell bodies ( Fig. 9E ) indicated a 46.20 ± 12.41% loss of TH neurons after MCAO (p = 0.03), reduced to a 21.11 ± 6.65% loss after grafting (p = 0.02) (Fig. 9F ), corresponding to a 47% protection.
DISCuSSIOn
This study shows that intracerebral transplantation of hiPSC-NPCs in the subacute phase of cerebral ischemia has the potential to reverse functional deficits and to limit degeneration of remote brain structures connected to the lesion site.
On the cell biology aspect, this study firstly confirmed that hiPSC and hESC can respond to the same differentiation protocol. NPCs were derived according to the dual-SMAD inhibitor protocol developed for hESCs, based on the inhibition of nodal/activin and BMP signaling pathways and resulting in accelerated commitment of pluripotent SCs (PSCs) into NSCs (8). A main advantage of the NSC protocol is the rapid production of large pools of homogenous NPCs after 5-7 days of differentiation from frozen stocks. This protocol reduces individual differences in neural commitment among PSCs (8).
Effective cell replacement therapy critically relies on the ability of transplanted progenitors to generate neurons with topographically relevant phenotypes. Striatal stroke induces massive loss of medium spiny GABAergic neurons, leading to the disruption of the striatonigral loop. As described for hESC-NPCs in this model (6,42), grafted hiPSC-NPCs accurately generated long-projection GABAergic neurons characterized by the D1 receptor second messenger DARPP-32. The low percentage of DARPP-32 neurons observed in grafts can be attributed to the lack of particular commitment during NPC differentiation and might be improved by specific differentiation protocols.
The second requirement for cell replacement therapy is accurate reconstruction of disrupted pathways (13). The ability of human neural progenitors to extend axons into the adult rat brain was first described by Wictorin and collaborators after excitotoxic striatal lesion (51). Subsequent studies have histologically (19) and electrophysiologically (6, 11, 19) reported synaptic contacts between human NPCs and the adult rodent brain in stroke models. The possibility for human grafted neurons to form long-distance axonal projections is less documented and controversial. On one hand, few retrogradely labeled axons were observed in cortical transplants after injection of a tracer into the thalamus (16). Limited projection from grafted cortical tissue and the underlying striatum was reported in a model of cortical ischemia (44). On the other hand, Gaillard et al. observed specific connections between murine homotopic nigral transplants and the host striatum in a model of Parkinson's disease (14) and from murine ESC-NPCs intracortical transplants to the host spinal cord (15). Reconstruction of the striatonigral loop was also achieved by simultaneous intrastriatal and intranigral grafting (31). A major result of our study was the fact that grafted hiPSC-NPCs extended axons toward the remote host SN with great specificity. This suggests that hiPSC-NPCs have the potential to recognize their target over long distances in the adult postischemic brain. The molecular content of the dialogue that establishes between grafted cells and the recipient brain remains to be understood. It might relate to the particularly prone-to-remodeling state of the poststroke brain (32). Alternatively, axonal extension in a xenograft situation might result from an insensibility of human axons to the adult rat brain inhibitory molecules (41) that would normally prevent the growth of rat axons. Reciprocity of this dialogue was suggested by the rapid sprouting of hostderived TH fibers into the grafts. The importance of host afferents in graft development has been emphasized in previous studies (12, 29) and could have played a role in guiding the terminal differentiation of grafted neurons.
For cell replacement to be causally linked to restoration of impaired functions, a temporal relationship should have existed between the maturation of graft-derived GABAergic neurons in the host striatum and the kinetics of functional recovery. However, improvements of sensorimotor functions in the adhesive removal test occurred very rapidly and were temporally dissociated from both the maturation of GABAergic neurons in grafts and axonal projections to host target areas, which occurred weeks later. This temporal discrepancy suggests the existence of mechanisms unrelated to the maturation and integration of grafted cells. Non cell-autonomous mechanisms have been evoked as major mediators of SCs effects in stroke, including with NPCs (5, 26, 35, 36, 38, 43, 53) . They are commonly attributed to the release, by immature exogenous cells, of neuroprotective, antioxidant, and anti-inflammatory molecules that can both limit degeneration and improve the structural reorganization of the post-stroke brain. The characterization of this dialogue in our paradigm deserves further investigations.
In contrast with the rapid recovery of sensorimotor functions, improvements of motor ability in the apomorphin-induced test established slowly. Apomorphin is an agonist of dopaminergic receptors that requires maturation of striatal neurons to be effective. The time course of motor recovery in this test nicely corresponded to the maturation of DARPP-32 neurons and to axonal projection to the SN.
Secondary alteration in areas functionally related to the lesion site after stroke has been described in patients (50) and animal models (33, 46) and greatly contributes to long-term functional impairments. The reduction of TH fibers in the striatum directly correlates with the atrophy of the SN (22), and striatal administration of trophic factors after lesion of SN axons protects against SN degeneration. In addition, intrastriatal grafting of mesenchymal SCs reduced the sensitivity of SN neurons to the toxicity of 6-hydroxydopamine (4,37), showing that SCs can exert a protective effect on SN neurons. We propose that the trophic effect exerted on host SN afferents by the graft was instrumental in promoting TH afferent sprouting into the graft and protecting the SN from atrophy, leading to rapid restoration of sensorimotor functions.
COnCluSIOnS
The driving force of current SC therapy research is to achieve a comprehensive understanding of the mechanisms by which transplanted cells restore lost functions.
So far, reported mechanisms include bystander effects nonrelated to intracerebral integration of exogenous cells and effects that directly rely on this integration. Due to its pathogenic characteristics, stroke can uniquely benefit from this duality. In the acute phase, cell death and inflammation predominates and trophic, angiogenic, and/ or anti-inflammatory actions can reduce the severity of infarction without cell engraftment. In contrast, the postacute and chronic phases are times for intense axonal and synaptic reorganization that can be efficiently supported by integrated cells. As schematized in Figure 10 , hiPSC-NPCs might act both rapidly with unspecific trophic effects and, secondarily, through integration and reconstruction of connections with host structures. A final step is needed before hiPSC-derived progenies enter the clinic, which relies on improvements of both the quality (to limit genetic and epigenetic modifications) and the availability of cells. The production of "patient-tailored" hiPSC, which could avoid transplant rejection, is a months-taking procedure and might not fit with the emergency requirements of stroke treatment. In contrast, the iPSC strategy allows the derivation of HLA-compatible cell banks that might provide the ideal cell source for cell replacement therapy or more generally SC therapy in stroke.
ACKNOWLEDGMENTS: We thank C. André for teratoma formation and analysis, X. Nissan for qPCR, M. Feyeux for cell culture, C. Varella for karyotyping, N. Lefort for FACS, and A. Günther-Kern and I. Heinemann for animal surgery and staircase testing. This work was performed in and granted by the STEMS ("Preclinical analysis of stem cell therapy for stroke") FP6 European project. It was supported by the Association Française contre les Myopathies (AFM) and the grant 1M0538 from the Ministry of Education, Youth, and Sports of the Czech Republic. The authors declare no conflicts of interest. Figure 10 . Suggested effects of hiPSC-NPCs grafted into the postischemic brain. Reciprocal connections link the substantia nigra (SN) to the striatum (STR). Stroke (MCAO) depletes the STR neuronal populations and deprives SN of both afferent and target cells, resulting in atrophy and partial cell death (no graft). Grafting (MCAO + Graft) firstly rescues the atrophy by providing SN striatal afferents with new targets and by promoting SN axonal sprouting (1. Trophic effect). Secondly, with maturation of transplanted cells, reconstruction of the STR-SN loop allows maintenance of functions (2. Reconstruction).
ReFeRenCeS
